In an effort to improve the issue of radiotherapy treatments, we tested whether S-nitrosocaptopril, a molecule combining a NO donor and an angiotensin converting enzyme inhibitor (ACE inhibitor), could temporarily improve the hemodynamic status of experimental tumors. We monitored the effect of S-nitrosocaptopril in TLT tumors using non rinvasive magnetic resonance techniques. We identified a time window during which tumor oxygenation was improved, as a result of a combined effect on tumor blood flow and oxygen consumption. Consequently, the administration of S-nitrosocaptopril contributed to the increase in efficacy of radiation therapy, an effect that was not observed with captopril alone.
Jordan, B., Peeterbroeck, J., Karroum, O., Diépart, C., Magat, J., Grégoire, V., & Gallez, B. (2010). Captopril and S-nitrosocaptopril as potent radiosensitizers : comparative study and underlying mechanisms. Cancer Letters, 293(2), 213-219. https://doi.org/10.1016/j.canlet.2010.01.016 (Original work published 2010)